Similar articles for PMID: 35710733

Year	Number of Results
1999	1
2011	1
2012	1
2013	4
2014	4
2015	6
2016	8
2017	3
2018	11
2019	23
2020	25
2021	29
2022	9

1

¹⁸F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients.

Girum KB, Rebaud L, Cottereau AS, Meignan M, Clerc J, Vercellino L, Casasnovas O, Morschhauser F, Thieblemont C, Buvat I. Girum KB, et al. J Nucl Med. 2022 Jun 16:jnumed.121.263501. doi: 10.2967/jnumed.121.263501. Online ahead of print. J Nucl Med. 2022. PMID: 35710733

2

Deep-Learning ¹⁸F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma.

Capobianco N, Meignan M, Cottereau AS, Vercellino L, Sibille L, Spottiswoode B, Zuehlsdorff S, Casasnovas O, Thieblemont C, Buvat I. Capobianco N, et al. J Nucl Med. 2021 Jan;62(1):30-36. doi: 10.2967/jnumed.120.242412. Epub 2020 Jun 12. J Nucl Med. 2021. PMID: 32532925 Free PMC article.

3

Prognostic value of metabolic tumour volume on baseline ¹⁸F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Shagera QA, Cheon GJ, Koh Y, Yoo MY, Kang KW, Lee DS, Kim EE, Yoon SS, Chung JK. Shagera QA, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1417-1427. doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30941463

4

Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT^†.

Cottereau AS, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I. Cottereau AS, et al. Ann Oncol. 2021 Mar;32(3):404-411. doi: 10.1016/j.annonc.2020.11.019. Epub 2020 Dec 3. Ann Oncol. 2021. PMID: 33278600 Free article.

5

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Decazes P, Becker S, Toledano MN, Vera P, Desbordes P, Jardin F, Tilly H, Gardin I. Decazes P, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1672-1679. doi: 10.1007/s00259-018-4041-0. Epub 2018 Apr 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29705879

6

Predictive value of baseline ¹⁸F-FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B-cell lymphoma receiving R-CHOP chemotherapy.

Zhu L, Meng Y, Guo L, Zhao H, Shi Y, Li S, Wang A, Zhang X, Shi J, Zhu J, Xu K. Zhu L, et al. Oncol Lett. 2021 Feb;21(2):132. doi: 10.3892/ol.2020.12393. Epub 2020 Dec 18. Oncol Lett. 2021. PMID: 33552253 Free PMC article.

7

Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.

Blanc-Durand P, Jégou S, Kanoun S, Berriolo-Riedinger A, Bodet-Milin C, Kraeber-Bodéré F, Carlier T, Le Gouill S, Casasnovas RO, Meignan M, Itti E. Blanc-Durand P, et al. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1362-1370. doi: 10.1007/s00259-020-05080-7. Epub 2020 Oct 24. Eur J Nucl Med Mol Imaging. 2021. PMID: 33097974

8

Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on ¹⁸ F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma.

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG). Senjo H, et al. Cancer Med. 2019 Mar;8(3):953-962. doi: 10.1002/cam4.1973. Epub 2019 Feb 20. Cancer Med. 2019. PMID: 30790452 Free PMC article.

9

Prognostic Impact of Pretreatment 2-[¹⁸F]-FDG PET/CT Parameters in Primary Gastric DLBCL.

Albano D, Dondi F, Mazzoletti A, Bellini P, Giubbini R, Bertagna F. Albano D, et al. Medicina (Kaunas). 2021 May 14;57(5):498. doi: 10.3390/medicina57050498. Medicina (Kaunas). 2021. PMID: 34069203 Free PMC article.

10

Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.

Guo B, Tan X, Ke Q, Cen H. Guo B, et al. PLoS One. 2019 Jan 9;14(1):e0210224. doi: 10.1371/journal.pone.0210224. eCollection 2019. PLoS One. 2019. PMID: 30625203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed